2. Louisirirotchanakul S, Kanoksinsombat C, Theamboonlert A, Puthavatana P, Wasi C, Poovorawan Y. Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits. Viral Immunology 2004;17:440-444.
3. Klein HG, Anstee DJ. Mollison's blood transfusion in clinical medicine 2005;11th ed. Oxford: Blackwell Publishing. 701-773.
4. Donegan E, Stuart M, Niland JC. Transfusion Safety Study Group. Infection with human immunodeficiency virus type I (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733.
7. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421.
8. Ludlam CA, Turner ML. Managing the risk of transmission of variant Creutzfeldt-Jakob disease by blood products. British Journal of Haematology 2005;132:13-24.
9. Guidance for Industry, Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products
http://www.fda.gov/cber/gdlns/cjdvcjd.pdf